Patent Foramen Ovale after Cryptogenic Stroke — Assessing the Evidence for Closure

The benefit of closing a patent foramen ovale after a cryptogenic stroke has been an open question. The FDA recently approved the Amplatzer PFO Occluder in light of a nonsignificant reduction in recurrent ischemic stroke with the device and a favorable safety profile.